license extension

Showing 1 posts of 1 posts found.

Levosert® (52mg levonorgestrel intrauterine system [IUS]) receives an 8-year licence extension in the UK for contraception

August 5, 2024
Research and Development Contraception, UK, contraception, license extension

Gedeon Richter UK Ltd. (“Richter”) today announced that the Medicines Health Regulatory Authority (MHRA) has authorised an extension to the …

The Gateway to Local Adoption Series

Latest content